An autoimmune-mediated strategy for prophylactic breast cancer vaccination

Nature Medicine

Volumn 16, Issue 7, 2010, Pages 799-803

  Jaini, Ritika ^a   Kesaraju, Pavani ^a,b   Johnson, Justin M ^a   Altuntas, Cengiz Z ^a,c   Jane Wit, Daniel ^a,d   Tuohy, Vincent K ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTALBUMIN; AUTOANTIGEN; CANCER VACCINE; PROTEIN; RECOMBINANT ALPHA LACTALBUMIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BREAST; BREAST CANCER; BREAST CARCINOMA; BREAST EPITHELIUM; CANCER IMMUNIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LACTATION; MASTITIS; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; CANCER VACCINES; CELL LINE, TUMOR; FEMALE; HUMANS; LACTALBUMIN; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC;

MUS; MUS MUSCULUS;

EID: 77954538586     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2161     Document Type: Article

References (26)

1. Rosenberg, S.A., Yang, J.C. & Restifo, N.P. Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10, 909-915 (2004).
2. Lollini, P.L., Cavallo, F., Nanni, P. & Forni, G. Vaccines for tumour prevention. Nat. Rev. Cancer 6, 204-216 (2006).
3. Lee, A.K. et al. Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study. Am. J. Clin. Pathol. 84, 687-696 (1985).
4. Wrba, F. et al. Prognostic signifcance of immunohistochemical parameters in breast carcinomas. Pathol. Res. Pract. 183, 277-283 (1988).
5. Cohen, C., Sharkey, F.E., Shulman, G., Uthman, E.O. & Budgeon, L.R. Tumor-associated antigens in breast carcinomas. Prognostic signifcance. Cancer 60, 1294-1298 (1987).
6. Nagamatsu, Y. & Oka, T. Purifcation and characterization of mouse α-lactalbumin and preparation of its antibody. Biochem. J. 185, 227-237 (1980).
7. Ren, J., Stuart, D.I. & Acharya, K.R. α-lactalbumin possesses a distinct zinc binding site. J. Biol. Chem. 268, 19292-19298 (1993).
8. Vilotte, J.L. & Soulier, S. Isolation and characterization of the mouse α-lactalbumin-encoding gene: interspecies comparison, tissue-and stage-specifc expression. Gene 119, 287-292 (1992).
9. Vilotte, J.L., Soulier, S. & Mercier, J.C. Sequence of the murine α-lactalbumin-encoding cDNA: interspecies comparison of the coding frame and deduced pre-protein. Gene 112, 251-255 (1992).
10. Setiawan, V.W., Feigelson, H.S. & Henderson, B.E. Epidemiology and risk factors: an update. in Textbook of Breast Cancer: A Clinical Guide to Therapy 3rd edition; (eds. Bonadonna, G., Hortobagyi, G.N. & Valagussa, P.) 1-16 (Informa Healthcare/Taylor & Francis, Abingdon, England, 2006).
11. Dudley, A., McKinstry, W., Thomas, D., Best, J. & Jenkins, A. Removal of endotoxin by reverse phase HPLC abolishes anti-endothelial cell activity of bacterially expressed plasminogen kringle 5. Biotechniques 35, 724-726 (2003).
12. Baek, M.-J. et al. Increased frequencies of cochlin-specifc T cells in patients with autoimmune sensorineural hearing loss. J. Immunol. 177, 4203-4210 (2006).
13. Stinnakre, M.G., Vilotte, J.L., Soulier, S. & Mercier, J.C. Creation and phenotypic analysis of α-lactalbumin-defcient mice. Proc. Natl. Acad. Sci. USA 91, 6544-6548 (1994).
14. Guy, C.T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89, 10578-10582 (1992).
15. Guy, C.T., Cardiff, R.D. & Muller, W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954-961 (1992).
16. Hall, L., Craig, R.K., Davies, M.S., Ralphs, D.N. & Campbell, P.N. α-lactalbumin is not a marker of human hormone-dependent breast cancer. Nature 290, 602-604 (1981).
17. Li, X. et al. Transcriptional targeting modalities in breast cancer gene therapy using adenovirus vectors controlled by α-lactalbumin promoter. Mol. Cancer Ther. 4, 1850-1859 (2005).
18. Anderson, L.M. et al. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer. Gene Ther. 6, 854-864 (1999).
19. Anderson, L.M., Krotz, S., Weitzman, S.A. & Thimmapaya, B. Breast cancer-specifc expression of the Candida albicans cytosine deaminase gene using a transcriptional targeting approach. Cancer Gene Ther. 7, 845-852 (2000).
20. Perez-Diez, A. et al. CD4 cells can be more effcient at tumor rejection than CD8 cells. Blood 109, 5346-5354 (2007).
21. Marzo, A.L., Lake, R.A., Robinson, B.W. & Scott, B. T-cell receptor transgenic analysis of tumor-specifc CD8 and CD4 responses in the eradication of solid tumors. Cancer Res. 59, 1071-1079 (1999).
22. Ludewig, B. et al. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J. Exp. Med. 191, 795-804 (2000).
23. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune infammation. J. Exp. Med. 201, 233-240 (2005).
24. Zang, X. & Allison, J.P. The B7 family and cancer therapy: costimulation and coinhibition. Clin. Cancer Res. 13, 5271-5279 (2007).
25. Curiel, T.J. Tregs and rethinking cancer immunotherapy. J. Clin. Invest. 117, 1167-1174 (2007).
26. Altuntas, C.Z., Johnson, J.M. & Tuohy, V.K. Autoimmune targeted disruption of the pituitary-ovarian axis causes premature ovarian failure. J. Immunol. 177, 1988-1996 (2006).